JHLT: The Podcast

ISHLT
  • 5.0 (5)
  • LIFE SCIENCES
  • UPDATED MONTHLY

The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.

  1. Episode 75: A Look Back on 2025 in JHLT

    6D AGO

    Episode 75: A Look Back on 2025 in JHLT

    Happy new year and welcome to a new season of JHLT: The Podcast! In this year-end recap, the Digital Media Editors will each share one of their favorite studies from The Journal of Heart and Lung Transplantation in 2025. You'll get a look at some of the best science in advanced heart and lung failure from the past year.   Studies featured: Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR Gomberg-Maitland M, et al. JHLT Apr 2025 44(4):609 – 624. A consensus-based framework for the psychosocial evaluation of pediatric candidates for cardiothoracic transplant and ventricular assist devices Lefkowitz DS, et al. JHLT Apr 2025 44(4):487-502. ABO-incompatible heart transplants in children aged 2-9 years: A new paradigm in transplant? Hollis P, et al. JHLT Dec 2025 44(12):1910-1917. Heart transplantation in Ukraine during wartime: A retrospective cohort study of standard vs marginal donor heart transplantation outcomes Todurov B, et al. JHLT Nov 2025 44(11):1728-1734.   For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    14 min
  2. Episode 74: Outcomes for CTEPH patients with High Antiphospholipid Antibodies after Pulmonary Endarterectomy

    12/17/2025

    Episode 74: Outcomes for CTEPH patients with High Antiphospholipid Antibodies after Pulmonary Endarterectomy

    JHLT: The Podcast returns with an episode discussing the paper, "High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single-Center Retrospective Observational Cohort Study," from the December issue of JHLT.   They are joined by the first author, Camille Miard, MD, and senior author, François Stéphan, MD, PhD, both from the cardiothoracic intensive care unit at Hôpital Marie Lannelongue in Paris.   The discussion explores: Whether antiphospholipid antibody titers could predict postoperative outcomes for CTEPH patients undergoing pulmonary endarterectomy (PEA) How APS patients differed from non-APS patients in the PEA cohort The changes in clinical practice at Marie Lannelongue after the study's findings   For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    11 min
  3. Episode 73: Lung Transplant in Patients with Suspicious Lung Lesions

    12/03/2025

    Episode 73: Lung Transplant in Patients with Suspicious Lung Lesions

    On this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on the paper, "Lung transplant in patients with suspicious lung lesions: A single-center retrospective data analysis," which appears in the December issue of JHLT. They are joined by the senior author, Stefan Schwarz, MD, PhD, of the Department of Thoracic Surgery at the Medical University of Vienna. The discussion explores: Methods used to assess the probability of malignancy in the patient cohort The limitations of common scanning methods in assessing this type of transplant patient What the study confirms or changes about standards in clinical practice For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    11 min
  4. Episode 72: Impact of Donor-Specific Antibodies on Longitudinal Lung Function and BLAD

    11/05/2025

    Episode 72: Impact of Donor-Specific Antibodies on Longitudinal Lung Function and BLAD

    On this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on the paper, "Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction."   They are joined by the first author, Muhtadi Alnababteh, MD, Assistant Professor at the University of Maryland and Staff Clinician at the National Institutes of Health, and senior author Michael Keller, MD, of the Pulmonary and Critical Care division at the University of Maryland.   The discussion explores: Common characteristics of patients who developed donor-specific antibodies (DSA) Differences in outcomes depending on when DSA developed Associations between the development of DSA and antibody-mediated rejection, and related time frames For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    20 min
  5. Episode 71: Cardiogenic Shock Working Group: Patients on Impella 5.5 for more than 14 days

    10/15/2025

    Episode 71: Cardiogenic Shock Working Group: Patients on Impella 5.5 for more than 14 days

    On this episode of JHLT: The Podcast, the Digital Media Editors invite co-lead author Nir Uriel, MD, Director of Advanced Heart Failure and Cardiac Transplantation at New York Presbyterian Hospital and Professor of Medicine at Columbia University. Dr. Uriel joins to discuss the work of the Cardiogenic Shock Working Group (CSWG) and their recent paper, "Outcomes of patients supported on Impella 5.5 for more than 14 days: A Cardiogenic Shock Working Group registry analysis." The discussion explores: Why patients on longer duration of MCS had better survival but maintained similar rates of serious adverse events (SAEs) Why the study might show fewer SAEs than the literature historically shows How temporary MCS devices are selected in clinical settings in patients with cardiogenic shock The ongoing and upcoming activities of CSWG For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    21 min
  6. Episode 70: Passive Leg Raise and Occult HFpEF in Pulmonary Hypertension

    10/01/2025

    Episode 70: Passive Leg Raise and Occult HFpEF in Pulmonary Hypertension

    On this episode of JHLT: The Podcast, the Digital Media Editors invite author Dr. Ayumi Goda, from the Kyorin University Hospital in Tokyo, Japan, to discuss her team's paper, "Prevalence of occult HFpEF and age-specific efficacy of passive leg raise in pulmonary hypertension." The discussion explores: How clinical observations led to the idea for a study on whether the passive leg raise could unmask occult HFpEF The potential diagnostic value of the passive leg raise in differing patient populations Age-specific cutoffs that may influence what kind of testing to use in clinical practice For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    16 min

  7. 09/03/2025

    Episode 69: Optimal Pre-Transplant Duration with HeartMate III LVADs

    On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Ahmet Bilgili, from the University of Florida's Congenital Heart Center, and senior author Eric I. Jeng, MD, from the University of Florida's MCS program. Bilgili and Dr. Jeng discuss their paper, "Optimal pretransplant duration with HeartMate III left ventricular assist device: A contemporary analysis." The discussion explores: Prior gaps in the literature regarding contemporary HM3 outcomes in relation to transplantation—and the study's potential influence on policy Which length of HM3 support influenced better post-transplant outcomes—and which ages were most influenced How these findings might change standard practice For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    16 min
  8. Episode 68: DCD lung procurement in the UK

    08/20/2025

    Episode 68: DCD lung procurement in the UK

    On this episode of JHLT: The Podcast, the Digital Media Editors invite first author Luke Williams, a cardiothoracic surgery trainee at Royal Papworth Hospital, NHS Blood and Transplant Clinical Research Fellow, and a PhD student at Cambridge University in the UK. Luke discusses his paper, "The United Kingdom's experience of controlled donation after circulatory death direct procurement of lungs with concomitant abdominal normothermic regional perfusion with an analysis of short-term outcomes."   The discussion explores: Requirements, regulations, and practices in the UK around DCD procurement and A-NRP How survival rates differ and what they might imply about primary graft dysfunction in DCD versus DBD Further work planned in the area in the UK and throughout Europe For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    13 min
See All (76)

Ratings & Reviews

5
out of 5
5 Ratings

About

The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.

Information

  • Creator
    ISHLT
  • Years Active
    2021 - 2026
  • Episodes
    76
  • Rating
    Clean
  • Show Website
    JHLT: The Podcast

You Might Also Like